Insights Into the Effects of Mucosal Epithelial and Innate Immune Dysfunction in Older People on Host Interactions With Streptococcus pneumoniae.

Frontiers in Cellular and Infection Microbiology
Caroline M WeightRobert S Heyderman

Abstract

In humans, nasopharyngeal carriage of Streptococcus pneumoniae is common and although primarily asymptomatic, is a pre-requisite for pneumonia and invasive pneumococcal disease (IPD). Together, these kill over 500,000 people over the age of 70 years worldwide every year. Pneumococcal conjugate vaccines have been largely successful in reducing IPD in young children and have had considerable indirect impact in protection of older people in industrialized country settings (herd immunity). However, serotype replacement continues to threaten vulnerable populations, particularly older people in whom direct vaccine efficacy is reduced. The early control of pneumococcal colonization at the mucosal surface is mediated through a complex array of epithelial and innate immune cell interactions. Older people often display a state of chronic inflammation, which is associated with an increased mortality risk and has been termed 'Inflammageing'. In this review, we discuss the contribution of an altered microbiome, the impact of inflammageing on human epithelial and innate immunity to S. pneumoniae, and how the resulting dysregulation may affect the outcome of pneumococcal infection in older individuals. We describe the impact of the pneumococc...Continue Reading

References

Sep 1, 1992·Journal of Gerontology·A B ThompsonS I Rennard
Mar 1, 1996·American Journal of Respiratory and Critical Care Medicine·K C MeyerK Peterson
Jul 9, 1999·The Journal of Infectious Diseases·H BruunsgaardB K Pedersen
Jan 27, 2000·Journal of Leukocyte Biology·C WenischW Hörl
Apr 3, 2001·American Journal of Respiratory and Critical Care Medicine·J C HoK W Tsang
Mar 19, 2002·American Journal of Respiratory and Critical Care Medicine·Vladimir KaplanWalter T Linde-Zwirble
Feb 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Richard MalleyDouglas T Golenbock
Feb 12, 2004·The Lancet Infectious Diseases·Jean-Paul Janssens, Karl-Heinz Krause
Sep 17, 2005·American Journal of Respiratory and Critical Care Medicine·Sachin YendeStephen B Kritchevsky
Jan 5, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·David van DuinAlbert C Shaw
Sep 20, 2008·PLoS Pathogens·Ying-Jie LuRichard Malley
Dec 17, 2008·Current Opinion in Hematology·Anastasia Nijnik, Robert E W Hancock
Jun 11, 2009·The Journal of Clinical Investigation·Zhe ZhangJeffrey N Weiser
Jun 13, 2009·PLoS Pathogens·Daniel M WeinbergerMarc Lipsitch
Jul 10, 2009·The Journal of Infectious Diseases·Ernesto HinojosaCarlos J Orihuela
Sep 15, 2009·Cell Host & Microbe·Jae-Min YukEun-Kyeong Jo
Nov 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tatsuya SaitohShizuo Akira
Jan 1, 2009·Aging Health·John E StupkaMarcos I Restrepo
Aug 13, 2010·Journal of Clinical Immunology·Joseph NyugenSudhir Gupta
Jul 21, 2011·The Journal of Biological Chemistry·Takuya SuzukiSoichi Tanabe
Aug 24, 2012·Expert Review of Vaccines·Birgit SimellUNKNOWN Pneumococcal Carriage Group
Oct 2, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sarah J GlennieRobert S Heyderman
Dec 12, 2012·The Journal of Steroid Biochemistry and Molecular Biology·David A JolliffeAdrian R Martineau
Feb 2, 2013·American Journal of Respiratory and Critical Care Medicine·Daniela M FerreiraStephen B Gordon
Feb 27, 2013·The Cochrane Database of Systematic Reviews·Sarah MoberleyRoss M Andrews
Jun 19, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·J E Castañeda-DelgadoB Rivas-Santiago
Aug 14, 2013·Nature Reviews. Genetics·Ana M ValdesTim D Spector
Mar 29, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dana N MitzelHeather W Stout-Delgado

❮ Previous
Next ❯

Citations

Aug 12, 2021·Trends in Molecular Medicine·Bharathi SundareshTim van Opijnen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.